Storm pushes into New England, battering Northeast for second day
Heavy snow was expected in Maine and other areas after more than a foot fell on New York City. — NYT: Top Stories
News Now!, Weather
News Now!, Politics
Impeachment managers call Trump ‘singularly responsible’ for riot
Filings due today from the House impeachment managers and former President Donald J. Trump’s lawyers will outline their cases ahead of his trial next week. Meanwhile, President Biden will sign executive orders on immigration. — NYT: Top Stories
Business, Technology
Catalent, Inc. reports second quarter fiscal 2021 results
Q2’21 net revenue of $910.8 million increased 26% as-reported, or 24% in constant currency, compared to Q2’20. Organic, constant currency net revenue grew 17%, compared to Q2’20. Q2’21 net earnings of $88.4 million increased 94%, or 88% in constant currency, compared to
Health Care, Local News, News Now!
101 recipes to cook on a snowy day
Here’s a selection of dishes for when the snow has fallen and you’re housebound and hungry. Soups are great. Try warmer meals. — NYT: Top Stories
Media & Communications, News Now!, Sports & Gaming
Reddit C.E.O. on GameStop and the forum shaking up Wall Street
Steve Huffman on the subreddit causing chaos on Wall Street. — NYT: Top Stories
Local News, News Now!, Weather
Major storm hits the Northeast and disrupts travel for millions
A winter storm expected to bring at least a foot of snow to the region has created hazardous conditions and caused flight cancellations. — NYT: Top Stories
Health Care, News Now!
U.S. vaccination rollout gathers speed, as threat of variants grows
Amid signs of progress, scientists warned the spread of coronavirus variants must be contained before they become dominant. — NYT: Top Stories
Business, Health Care, Science
Legend Biotech announces BCMA CAR-T Therapy Cilta-cel accepted for accelerated assessment in Europe for the treatment of relapsed and/or refractory multiple myeloma
SOMERSET, N.J. — (BUSINESS WIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that the Committee for Medicinal Products for